Researchers develop a new prodrug and localized drug delivery platform for selective treatment of cancer

A new collaborative study reports the discovery and application of a novel therapeutic strategy to selectively target EGFR and other kinases with controlled release in tumor microenvironments to improve therapeutic efficacy, with promising results. The research is published in Bioorganic Chemistry.

Originally published at Phys.org